Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management
出版年份 2017 全文链接
标题
Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management
作者
关键词
-
出版物
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 23, Issue 11, Pages 1954
出版商
Baishideng Publishing Group Inc.
发表日期
2017-03-19
DOI
10.3748/wjg.v23.i11.1954
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Safety of a Four-factor Prothrombin Complex Concentrate Versus Plasma for Vitamin K Antagonist Reversal: An Integrated Analysis of Two Phase IIIb Clinical Trials
- (2016) Truman J. Milling et al. ACADEMIC EMERGENCY MEDICINE
- The association between non-vitamin K antagonist oral anticoagulants and gastrointestinal bleeding: a meta-analysis of observational studies
- (2016) Ying He et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Reversal of novel oral anticoagulants
- (2016) Elsayed Abo-Salem et al. CURRENT OPINION IN PHARMACOLOGY
- Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2
- (2016) Hans-Christoph Diener et al. EUROPEAN HEART JOURNAL
- A real world data of dabigatran etexilate: multicenter registry of oral anticoagulants in nonvalvular atrial fibrillation
- (2016) Bunyamin Yavuz et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors
- (2016) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation
- (2016) David J. Graham et al. JAMA Internal Medicine
- Systematic review with meta-analysis: the risk of major gastrointestinal bleeding with non-vitamin K antagonist oral anticoagulants
- (2015) D. Caldeira et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis
- (2015) K. E. Chan et al. CIRCULATION
- Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in Japanese Patients With Atrial Fibrillation
- (2015) Keitaro Senoo et al. CIRCULATION JOURNAL
- Impact of new oral anticoagulants on gastrointestinal bleeding in atrial fibrillation: A meta-analysis of interventional trials
- (2015) Lorenzo Loffredo et al. DIGESTIVE AND LIVER DISEASE
- Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
- (2015) Hein Heidbuchel et al. EUROPACE
- Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study
- (2015) Esther W. Chan et al. GASTROENTEROLOGY
- Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal
- (2015) Gregory Y.H. Lip et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Matching the NOAC to the Patient
- (2015) Gregory Y.H. Lip et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH
- (2015) G. D. Barnes et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Idarucizumab for Dabigatran Reversal
- (2015) Charles V. Pollack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Practical management of bleeding in patients receiving non-vitamin K antagonist oral anticoagulants
- (2015) Charles V. Pollack et al. THROMBOSIS AND HAEMOSTASIS
- Safety of the direct-acting anticoagulants in patients with atrial fibrillation: a meta-analysis
- (2015) Fen Rong et al. THROMBOSIS RESEARCH
- Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study
- (2015) H.-Y. Chang et al. BMJ-British Medical Journal
- Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
- (2015) N. S. Abraham et al. BMJ-British Medical Journal
- Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study
- (2015) H.-Y. Chang et al. BMJ-British Medical Journal
- Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
- (2015) N. S. Abraham et al. BMJ-British Medical Journal
- Effectiveness and Safety of Dabigatran and Warfarin in Real-World US Patients With Non-Valvular Atrial Fibrillation: A Retrospective Cohort Study
- (2015) J. C. Lauffenburger et al. Journal of the American Heart Association
- Bleeding Rates in Veterans Affairs Patients with Atrial Fibrillation Who Switch from Warfarin to Dabigatran
- (2014) Mary S. Vaughan Sarrazin et al. AMERICAN JOURNAL OF MEDICINE
- The successful management of dabigatran-associated critical end-organ bleeding with recombinant factor VIIa
- (2014) K. T. Htun et al. ANNALS OF HEMATOLOGY
- Anticoagulant-related gastrointestinal bleeding—could this facilitate early detection of benign or malignant gastrointestinal lesions?
- (2014) Andreas Clemens et al. ANNALS OF MEDICINE
- The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis
- (2014) C. Chai-Adisaksopha et al. BLOOD
- Activated prothrombin complex concentrate for the prevention of dabigatran- associated bleeding
- (2014) Henna Wong et al. BRITISH JOURNAL OF HAEMATOLOGY
- Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)
- (2014) Jonathan L. Halperin et al. CIRCULATION
- Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial
- (2014) J. P. Piccini et al. EUROPEAN HEART JOURNAL
- Management of new oral anticoagulants related life threatening or major bleedings in real life: a brief report
- (2014) Luca Masotti et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel
- (2014) Raffaele de Caterina et al. THROMBOSIS AND HAEMOSTASIS
- Novel anticoagulants
- (2013) Neena S. Abraham et al. CURRENT OPINION IN GASTROENTEROLOGY
- New Oral Anticoagulants Increase Risk for Gastrointestinal Bleeding: A Systematic Review and Meta-analysis
- (2013) I. Lisanne Holster et al. GASTROENTEROLOGY
- Novel oral anticoagulants in gastroenterology practice
- (2013) Jay Desai et al. GASTROINTESTINAL ENDOSCOPY
- Efficacy and Safety of Dabigatran Etexilate and Warfarin in “Real-World” Patients With Atrial Fibrillation
- (2013) Torben Bjerregaard Larsen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran and Postmarketing Reports of Bleeding
- (2013) Mary Ross Southworth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran Versus Warfarin
- (2013) Masatsugu Hori et al. STROKE
- Gastrointestinal bleeding with the new oral anticoagulants – defining the issues and the management strategies
- (2013) Jay Desai et al. THROMBOSIS AND HAEMOSTASIS
- Effective elimination of dabigatran by haemodialysis
- (2013) Stephan Formella et al. THROMBOSIS AND HAEMOSTASIS
- Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) Versus Warfarin in Patients With Atrial Fibrillation
- (2012) Corey S. Miller et al. AMERICAN JOURNAL OF CARDIOLOGY
- Prevention of VTE in Orthopedic Surgery Patients
- (2012) Yngve Falck-Ytter et al. CHEST
- Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial
- (2012) Antonio L. Dans et al. CIRCULATION
- The role of endoscopy in the management of acute non-variceal upper GI bleeding
- (2012) Joo Ha Hwang et al. GASTROINTESTINAL ENDOSCOPY
- Danger Ahead: Watch Out for Indirect Comparisons!⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.
- (2012) Christopher P. Cannon et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
- (2011) John W. Eikelboom et al. CIRCULATION
- Dabigatran Etexilate
- (2011) Graeme J. Hankey et al. CIRCULATION
- Pharmacodynamic and pharmacokinetic basics of rivaroxaban
- (2011) Reinhold Kreutz FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
- (2010) Ron Pisters et al. CHEST
- Factor V Leiden thrombophilia
- (2010) Jody Lynn Kujovich GENETICS IN MEDICINE
- Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation
- (2010) Gregory Y.H. Lip et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
- (2010) Joachim Stangier et al. THROMBOSIS AND HAEMOSTASIS
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based
- (2008) M. Levi et al. BLOOD
- Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjects
- (2008) Dagmar Kubitza et al. CURRENT MEDICAL RESEARCH AND OPINION
- Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans
- (2008) N. Raghavan et al. DRUG METABOLISM AND DISPOSITION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now